Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1953 1
1955 1
1962 1
1965 1
1966 1
1968 3
1969 1
1971 2
1972 1
1974 3
1975 1
1976 2
1978 2
1979 1
1980 2
1981 2
1983 5
1984 4
1985 2
1986 2
1987 5
1988 7
1989 2
1990 6
1991 6
1992 6
1993 7
1994 8
1995 8
1996 8
1997 4
1998 9
1999 5
2000 2
2001 10
2002 6
2003 6
2004 8
2005 9
2006 9
2007 10
2008 13
2009 9
2010 9
2011 15
2012 9
2013 9
2014 12
2015 22
2016 17
2017 20
2018 14
2019 16
2020 32
2021 1
Text availability
Article attribute
Article type
Publication date

Similar Articles for PMID: 17089680

347 results
Results by year
Filters applied: . Clear all
Page 1
Long-term stabilization of a new freeze-dried and albumin-free formulation of recombinant human interferon alpha 2b.
Ruiz L, Reyes N, Sotolongo J, Aroche K, Aldana R, Báez R, Hardy E. Ruiz L, et al. PDA J Pharm Sci Technol. 2006 Jan-Feb;60(1):72-8. PDA J Pharm Sci Technol. 2006. PMID: 17089680
Stabilization of a freeze-dried recombinant streptokinase formulation without serum albumin.
López M, González LR, Reyes N, Sotolongo J, Pujol V. López M, et al. J Clin Pharm Ther. 2004 Aug;29(4):367-73. doi: 10.1111/j.1365-2710.2004.00573.x. J Clin Pharm Ther. 2004. PMID: 15271104
Some factors affecting the stability of interferon alpha 2b in solution.
Ruiz L, Reyes N, Aroche K, Báez R, Aldana R, Hardy E. Ruiz L, et al. Biologicals. 2006 Mar;34(1):15-9. doi: 10.1016/j.biologicals.2005.07.002. Epub 2005 Sep 26. Biologicals. 2006. PMID: 16188456
Stability Studies of a Freeze-Dried Recombinant Human Epidermal Growth Factor Formulation for Wound Healing.
Santana H, García G, Vega M, Beldarraín A, Páez R. Santana H, et al. PDA J Pharm Sci Technol. 2015 May-Jun;69(3):399-416. doi: 10.5731/pdajpst.2015.01052. PDA J Pharm Sci Technol. 2015. PMID: 26048746
Long-term stabilization of recombinant human interferon alpha 2b in aqueous solution without serum albumin.
Ruiz L, Reyes N, Duany L, Franco A, Aroche K, Hardy Rando E. Ruiz L, et al. Int J Pharm. 2003 Oct 2;264(1-2):57-72. doi: 10.1016/s0378-5173(03)00388-0. Int J Pharm. 2003. PMID: 12972336
Stability of an extemporaneously prepared recombinant human interferon alfa-2b eye drop formulation.
Ruiz L, Rodriguez I, Baez R, Aldana R. Ruiz L, et al. Am J Health Syst Pharm. 2007 Aug 15;64(16):1716-9. doi: 10.2146/ajhp060472. Am J Health Syst Pharm. 2007. PMID: 17687060
In vitro stability of lyophilized and reconstituted recombinant activated factor VII formulated for storage at room temperature.
Nedergaard H, Vestergaard S, Jensen PT, Kristiansen MW, Jensen MB, Ostergaard PB, Norsell T, Bjerre J. Nedergaard H, et al. Clin Ther. 2008 Jul;30(7):1309-15. doi: 10.1016/s0149-2918(08)80055-0. Clin Ther. 2008. PMID: 18691990
Stabilization of a recombinant human epidermal growth factor parenteral formulation through freeze-drying.
Santana H, Sotolongo J, González Y, Hernández G, Chinea G, Gerónimo H, Amarantes O, Beldarraín A, Páez R. Santana H, et al. Biologicals. 2014 Nov;42(6):322-33. doi: 10.1016/j.biologicals.2014.07.005. Epub 2014 Sep 2. Biologicals. 2014. PMID: 25190208
Development of freeze-dried albumin-free formulation of recombinant factor VIII SQ.
Osterberg T, Fatouros A, Mikaelsson M. Osterberg T, et al. Pharm Res. 1997 Jul;14(7):892-8. doi: 10.1023/a:1012199816852. Pharm Res. 1997. PMID: 9244146
The effect of annealing on the stability of amorphous solids: chemical stability of freeze-dried moxalactam.
Abdul-Fattah AM, Dellerman KM, Bogner RH, Pikal MJ. Abdul-Fattah AM, et al. J Pharm Sci. 2007 May;96(5):1237-50. doi: 10.1002/jps.20947. J Pharm Sci. 2007. PMID: 17455341
347 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback